Peak6 »

Alnylam Pharmaceuticals shares owned by Peak6

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Peak6 from 13F filings

Historical chart of Peak6 investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Peak6 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Peak6

Quarter filed Position value Share count Share price at filing
2025-09-30 $24M 53k 456.00
2025-06-30 $11M 34k 326.09
2025-03-31 $4.2M 16k 270.02
2024-12-31 $14M 58k 235.31

More positions owned by Peak6

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Coreweave Com Cl A Call Option (CRWV)
Apple Call Option (AAPL)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New Call Option (MSTR)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Broadcom Call Option (AVGO)

View all positions for Peak6

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals